These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 12384847)
1. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia. Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847 [TBL] [Abstract][Full Text] [Related]
2. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia. Warnock AC; Rimland D Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975 [TBL] [Abstract][Full Text] [Related]
3. Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole. Fisher RG; Nageswaran S; Valentine ME; McKinney RE AIDS Patient Care STDS; 2001 May; 15(5):263-9. PubMed ID: 11530767 [TBL] [Abstract][Full Text] [Related]
4. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ; Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703 [TBL] [Abstract][Full Text] [Related]
5. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225 [TBL] [Abstract][Full Text] [Related]
6. Protect yourself from Pneumocystis carinii. AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia. Schrøder H; Agger KE; Rosthøj S; Carlsen NT; Schmiegelow K Dan Med Bull; 2001 Nov; 48(4):275-7. PubMed ID: 11767129 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703 [TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children. Goodwin SD Pharmacotherapy; 1993; 13(6):640-6. PubMed ID: 8302691 [TBL] [Abstract][Full Text] [Related]
10. P. carinii pneumonia in African children and the ineffectiveness of TMP-SMX prophylaxis. Cruciani M; Malena M; Mengoli C Clin Infect Dis; 2003 Apr; 36(7):937-9; author reply 939-40. PubMed ID: 12652402 [No Abstract] [Full Text] [Related]
11. [Trimethoprim-sulfamethoxazole as antibacterial prophylaxis during induction therapy of children with acute lymphatic leukemia]. Agger KE; Schrøder H; Rosthøj S; Carlsen NT; Schmiegelow K Ugeskr Laeger; 2002 Jan; 164(4):488-92. PubMed ID: 11838420 [TBL] [Abstract][Full Text] [Related]
12. Pneumocystis pneumonia in children receiving chemotherapy. Prasad P; Nania JJ; Shankar SM Pediatr Blood Cancer; 2008 Apr; 50(4):896-8. PubMed ID: 17458875 [TBL] [Abstract][Full Text] [Related]
13. Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia. Poulsen A; Demeny AK; Bang Plum C; Gjerum Nielsen K; Schmiegelow K Med Pediatr Oncol; 2001 Jul; 37(1):20-3. PubMed ID: 11466718 [TBL] [Abstract][Full Text] [Related]
14. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482 [TBL] [Abstract][Full Text] [Related]
17. Infections during induction therapy for children with acute lymphoblastic leukemia. the role of sulfamethoxazole-trimethoprim (SMX-TMP) prophylaxis. Rungoe C; Malchau EL; Larsen LN; Schroeder H Pediatr Blood Cancer; 2010 Aug; 55(2):304-8. PubMed ID: 20583218 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887 [TBL] [Abstract][Full Text] [Related]
19. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613 [TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR; J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]